A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel (LY640315) versus Clopidogrel in Subjects with Stable Atherosclerosis

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-005292-15

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to compare the pharmacodynamic effect of a prasugrel 60 mg Loading Dose with a clopidogrel 600 mg Loading Dose, as assessed by change in mean maximal platelet aggregation to 20 mM ADP at 2 hours after LD administration, in aspirin-treated subjects with stable atherosclerosis.


Critère d'inclusion

  • Stable atherosclerosis

Liens